Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction

There has been an immense effort by global pharmaceutical companies to develop anti-COVID-19 drugs, including small molecule-based RNA replication inhibitors via drug repositioning and antibody-based spike protein blockers related to cell entry by SARS-CoV-2. However, several limitations to their cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Soo, Kwon, Eun-Bin, Kim, Buyun, Chung, Hwan-Suck, Choi, Garam, Kim, Yeoun-Hee, Choi, Jang-Gi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604257/
https://www.ncbi.nlm.nih.gov/pubmed/36293371
http://dx.doi.org/10.3390/ijms232012516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604257/
https://www.ncbi.nlm.nih.gov/pubmed/36293371
http://dx.doi.org/10.3390/ijms232012516

Ejemplares similares